Skip to main content

Zonisamide News

FDA Approves Zonisade (zonisamide oral suspension) for the Treatment of Partial-Onset Seizures

The first and only FDA-approved zonisamide oral liquid formulation WOBURN, Mass., July 18, 2022 /PRNewswire/ – Azurity Pharmaceuticals, Inc., a private pharmaceutical company focused on developing...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Migraine Prevention, Migraine Prophylaxis, Benign Essential Tremor, Epilepsy, Seizures

Zonisamide patient information at Drugs.com